Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors.
Wang S, Beck R, Burd A, Blench T, Marlin F, Ayele T, Buxton S, Dagostin C, Malic M, Joshi R, Barry J, Sajad M, Cheung C, Shaikh S, Chahwala S, Chander C, Baumgartner C, Holthoff HP, Murray E, Blackney M, Giddings A.
Wang S, et al. Among authors: chander c.
J Med Chem. 2010 Feb 25;53(4):1473-82. doi: 10.1021/jm901476x.
J Med Chem. 2010.
PMID: 20121197